May 20th, 2022
Northpond Labs funds second Wyss Institute research project
Through the Laboratory for Bioengineering Research and Innovation, Northpond will sponsor SomaCode to support commercialization
News
April 28th, 2022
CytoTronics launches to tackle drug discovery and phenotypic screening
Startup advances a unique CMOS-powered drug discovery platform that opens a new dimension in cell-based screening
March 15th, 2022
Making steak from vegetable protein
Harvard researchers spin ‘muscle’ fibers from vegetable plant proteins, launching alternative meat start-up
March 7th, 2022
Wyss Institute’s eRapid sensor technology licensed to Antisoma Therapeutics
Low-cost, multiplexed, electrochemical biomarker detection platform will be commercialized in point-of-care diagnostics
February 23rd, 2022
Cantex licenses IP from Harvard to develop repurposed drug identified by Wyss Institute to treat inflammatory lung diseases including COVID-19
Organ Chip studies revealed azeliragon can reduce virus-associated inflammation in human lung tissue
